Dr Reddy's partners with Purdue University

The strategic partnership will focus on research in pharmaceutical processes and product development

id-100188082-1

The collaboration will include student engagement and faculty exchanges and may include a site at Purdue Research Park

Purdue University has signed a strategic partnership memorandum of understanding (MoU) with Dr Reddy's Laboratories(DRL), to strengthen pharmaceutical research and development. The intent is to forge a strong strategic partnership in a range of research areas and novel technologies.

Mr Suresh Garimella, Purdue University's executive vice-president for research and partnerships, and his counterpart Mr Amit Biswas, executive vice-president and global head of integrated product development, DRL, signed a memorandum of understanding, between the two organizations that will advance the Purdue Moves drug discovery initiative to translate basic research into life-changing treatments.

 Areas of planned collaborative research and education include targeted drug delivery, manufacturing technology, scale-up of pharmaceutical operations, process engineering, and research and development methodologies and technology. The collaboration will include student engagement and faculty exchanges and may include a site at Purdue Research Park.

"Purdue has tremendous strength in pharmaceutical drug discovery and development research, but we need additional partners to help translate our discoveries through to the delivery of a medicine or technology. Dr Reddy's is a global pharmaceutical company that shares our mission to accelerate the rate at which new, advanced treatments make it to the millions of patients in need of relief. This partnership combines strengths that could lead to world-changing research," said Mr Garimella.

"The long-term research partnership augurs well for DRL's philosophy of providing access to innovative, high-quality medicines to global patients at affordable cost," said Mr Biswas. He added, "Purdue University has talented researchers, unique instrumentation and an interdisciplinary approach to solving technology challenges that make them a perfect partner as we sharpen our focus on innovative drug development programs. We are thrilled to partner with Purdue. Together we can find innovative solutions to address unmet needs and improve the health of people all over the world."

 

Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X